|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| (Gain)/loss on disposal of fixed assets | |||||
| Impairment of intangibles | |||||
| Impairment of lease right-of-use asset and fixed assets | |||||
| Deferred taxes | |||||
| Loss on divestiture of business | |||||
| Accrued interest on note receivable – related party | |||||
| Note receivable - related party | |||||
| Change in valuation of contingent payment liability | |||||
| Gain on sale of trademark | |||||
| Recovery of receivables, related to the Payless ShoeSource bankruptcy | |||||
| Amortization of inventory step-up and other | |||||
| Changes, net of acquisitions, in: | |||||
| Accounts receivable | |||||
| Factor accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses, income tax receivables, prepaid taxes, and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued incentive compensation | |||||
| Leases and other liabilities | |||||
| Payment of contingent liability | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of businesses | |||||
| Capital expenditures | |||||
| Purchases of short-term investments | |||||
| Purchase of a trademark | |||||
| Maturity/sale of short-term investments | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings under credit facilities | |||||
| Repayments under credit facilities | |||||
| Cash dividends paid on common stock | |||||
| Common stock repurchased and net settlements of stock awards | |||||
| Financing costs paid | |||||
| Investment of noncontrolling interest | |||||
| Distributions to noncontrolling interest earnings | |||||
| Sale of minority interest of a subsidiary | |||||
| Proceeds from exercise of stock options | |||||
| Acquisition of incremental ownership of joint ventures | |||||
| Payment of contingent liability | |||||
| Proceeds from Lines of Credit | |||||
| Net cash provided by / (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents – beginning of year | |||||
| Cash and cash equivalents – end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest | |||||
| Income taxes | |||||
| Cash paid during the year for interest | |||||
Loading...